Patent EP0428980A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0428980A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Determination of HDL in whole blood

Assignee: Abbott Laboratories
•
Filing: 1990-11-13
•
Granted: —
•
Expires: 2010-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for separating HDL from whole blood anticoagulated with EDTA is disclosed. The method includes, as a first step, mixing the anticoagulated whole blood with an aqueous solution composed of magnesium cations and dextran sulfate 500 in such proportions and of such concentration (a) that substantially all of the LDL and VLDL lipoproteins and substantially all of the chylomicrons are precipitated while (b) substantially all of the HDL remains in solution. The method also includes the step of sedimenting the precipitated lipoproteins, the chylomicrons and the red blood cells by centrifuging, which can be low gravity centrifuging, and can include the step of determining the cholesterol, triglyceride, phospholipid or protein content of the supernatant. Also disclosed is a method wherein the reagent additionally contains a colored species which can be used to determine dilution of the supernatant, and which includes the additional steps of determining the dilution of the supernatant and the dilution factor, and multiplying the value determined for cholesterol, triglyceride, phospholipid or protein content of the supernatant times the dilution factor to determine the corresponding content of the blood sample.

Inventors

  • 👤 Michael W. Mc Gowan

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-09 06:17
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/92; C; C12; C12Q; C12Q1/00; C12Q1/60; G01N2800/00; G01N2800/04; G01N2800/044; Y; Y10; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/25625

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 77 words
A method for separating HDL from whole blood anticoagulated with EDTA which comprises mixing the whole blood with an aqueous solution composed of magnesium ⁺⁺ cations and dextran sulfate 500 in such proportions and of such concentration (a) that the LDL and VLDL lipoproteins and the chylomicrons are precipitated while (b) the HDL remains in solution, and sedimenting the precipitated lipoproteins, the chylomicrons and the red bloods cells by centrifuging at not more than 1,000 X gravity.
Claim 2
Independent Claim 77 words
A method for separating HDL from whole blood anticoagulated with EDTA which comprises mixing the whole blood with an aqueous solution composed of magnesium ⁺⁺ cations and dextran sulfate 500 in such proportions and of such concentration (a) that the LDL and VLDL lipoproteins and the chylomicrons are precipitated while (b) the HDL remains in solution, and sedimenting the precipitated lipoproteins, the chylomicrons and the red bloods cells by centrifuging at not more than 1,000 X gravity.
Claim 3
Dependent Claim 29 words
A method as claimed in claim 1 which additionally includes the step of determining the cholesterol, triglyceride, phospholipid or protein content of the supernatant obtained from the centrifuging step.
Claim 4
Dependent Claim 70 words
A method as claimed in claim 2 wherein the reagent additionally contains a colored species which can be used to determine dilution of the supernatant, and which includes the additional steps of determining the dilution of the supernatant and the dilution factor, and multiplying the value determined for cholesterol, triglyceride, phospholipid or protein content of the supernatant times the dilution factor to determine the corresponding content of the blood sample.
Claim 5
Dependent Claim 32 words
A method as claimed in claim 1 wherein substantially one volume of the blood sample is mixed with one volume of the aqueous solution of magnesium ⁺⁺ cations and dextran sulfate 500.
Claim 6
Dependent Claim 51 words
An aqueous solution composed of magnesium ⁺⁺ cations and dextran sulfate 500 in such proportions and of such concentration that, when a whole blood sample of suitable size is added to the solution, (a) the LDL and VLDL lipoproteins and the chylomicrons are precipitated while (b) the HDL remains in solution.
Claim 7
Dependent Claim 51 words
An aqueous solution composed of magnesium ⁺⁺ cations and dextran sulfate 500 in such proportions and of such concentration that, when a whole blood sample of suitable size is added to the solution, (a) the LDL and VLDL lipoproteins and the chylomicrons are precipitated while (b) the HDL remains in solution.
Claim 8
Dependent Claim 28 words
An aqueous solution as claimed in claim 5 which additionally contains a color body which enables the use of absorbance measurements to determine the dilution of the solution.
Claim 9
Dependent Claim 19 words
An aqueous solution as claimed in claim 5 wherein the magnesium ⁺⁺ ions are derived from a magnesium sulfate.
Claim 10
Dependent Claim 55 words
An aqueous solution as claimed in claim 6 wherein the magnesium ⁺⁺ ions are derived from a magnesium sulfate and are present in an amount of substantially mM/l, wherein the dextran sulfate 500 is present in an amount of substantially 1.0 g/l, and wherein the color body is an iron ⁺⁺ complex with 3-(2-pyridyl)-­5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag